Generic Name: Ticagrelor
Brand Name: Brilinta
Manufacturer: AstraZeneca Canada Inc
Indications: Thrombotic events in Acute Coronary Syndromes, Prevention
Submission Type: New
Project Status: Complete
Date Recommendation Issued: December 16, 2011
Recommendation Type: Do not list